Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Maltviron
- Development stage
- Unknown
- Lead developer
- P.B. Pharmaceuticals
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Maltviron is a multivitamin and mineral supplement formulated as a syrup, developed and manufactured by P.B. Pharmaceuticals. It is primarily used to treat or prevent nutritional deficiencies, particularly iron-deficiency anemia, and to support recovery during convalescence or general debility. The product typically contains a combination of malt extract, ferric ammonium citrate (a source of iron), and essential B-complex vitamins including thiamine (B1), riboflavin (B2), pyridoxine (B6), and cyanocobalamin (B12), along with nicotinamide. These components work synergistically to support red blood cell production, energy metabolism, and overall physiological well-being.
- Brand names
- Maltviron
Beyond the preview
Go deeper on Maltviron.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Maltviron.